Researcher Next
Create account
← Back to directory

John Crown

Researcher Next ID · RN-008229

Researcher · Medicine

St. Vincent's University Hospital

Dublin, Ireland

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
871
Citation count
38,923
H-index
89
i10-index
284

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
HER2/EGFR in Cancer Research
Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies
Monoclonal and Polyclonal Antibodies Research

Publications

  • Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

    New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1814017

  • The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study

    The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)71159-3

  • Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2011.41.0902

  • Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa0910383

  • Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer

    New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa064320

Current projects

    No projects listed.